Skip to main content

Ferroptosis in Hemolytic Disorders

  • Chapter
  • First Online:
Ferroptosis in Health and Disease

Abstract

Ferroptosis, an iron-dependent form of cell death, has emerged as clinically relevant in various settings. This chapter focuses on the current landscape of ferroptosis in the context of hemolytic disorders and the iron overload that can occur due to heightened erythropoietic drive and/or transfusions of red blood cells (RBCs). In hemolytic disorders, RBCs are typically destroyed at a faster rate than new RBCs can be generated by the bone marrow. Examples include various instances of anemia, hemoglobinuria, and methemoglobinemia. During active, ongoing hemolysis, iron is processed and recycled at a much higher rate than under normal conditions, creating opportunities to generate destructive free radicals and lipid peroxidation. Thus far, in the context of hemolysis and iron overload, ferroptosis has been studied in the settings of transfusions of storage-damaged RBCs, hemochromatosis, acute kidney injury, and hemorrhagic stroke. Given their clinical significance, continued research in hemolytic disorders has the potential to offer tremendous insight in terms of both understanding these disorders and developing potential therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven L. Spitalnik .

Editor information

Editors and Affiliations

Ethics declarations

This work was funded, in part, by NIH T32 AI106711 and F31 HL134284 (to LAY) and by NIH R01 HL115557 and R01 HL133049 (to SLS). The figures in this chapter were created using BioRender. LAY has no conflicts to report. SLS is on the Scientific Advisory Board of Hemanext, Inc. and is a Consultant to Tioma, Inc., neither role is relevant to the current contribution.

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Youssef, L.A., Spitalnik, S.L. (2019). Ferroptosis in Hemolytic Disorders. In: Tang, D. (eds) Ferroptosis in Health and Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-26780-3_15

Download citation

Publish with us

Policies and ethics